Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)
- Status
- COMPLETED
- Phase
- N/A
Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE4
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials
- Status
- COMPLETED
- Phase
- N/A
REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE1
Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept
- Status
- COMPLETED
- Phase
- PHASE2
Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms
- Status
- COMPLETED
- Phase
- NA
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2